North Central London
Joint Formulary
Sub Chapters : 08 Malignant disease and immunosuppression
Back to Chapters
Aldesleukin
Alkylating drugs
Anthracyclines and other cytotoxic antibiotics
Anti-androgens
Anti-lymphocyte monoclonal antibodies
Antimetabolites
Antiproliferative immunosuppressants
Bevacizumab
Bortezomib
Breast cancer
Brentuximab vedotin
Cetuximab
Corticosteroids and other immunosuppressants
Crisantaspase
Dacarbazine and Temozolomide
Drugs for cytotoxic-induced side-effects
Erlotinib
Glatiramer acetate
Gonadorelin analogues
Hydroxycarbamide
Imatinab
Interferon Alfa
Interferon beta
Interferon gamma
Ipilimumab
Mifamurtide
Mitotane
Natalizumab
Oestrogens
Other antineoplastic drugs
Other immunomodulating drugs
Pentostatin
Platinum compounds
Procarbazine
Progestogens
Prostate cancer and gonadorelin analogues
Protein kinase inhibitors
Somatostatin analogues
Taxanes
Topoisomerase I inhibitors
Trabectedin
Trastuzumab
Tretinoin
Unlicensed Medicines / Significant off-label use
Vinca alkaloids and etoposide
Vismodegib
Key
Full Site
